Who Semaglutide Is For and Who Should Avoid It Semaglutide is FDA-approved for several conditions, but it is not for everyone
The term medically managed weight loss refers to a comprehensive strategy for weight loss that includes the direction and assistance of medical professionals, such as doctors, registered dietitians, and other healthcare providers
Are looking for a lower published list price compared to brand-name alternatives without insurance coverage: If brand-name GLP-1 medications are financially out of reach - whether because of insurance denial, high copays, or no coverage - the compounded medication pricing (starting at approximately $75/month for semaglutide plus a $74.99 program fee, according to the company's FAQ) may make treatment accessible
Common side effects and their frequency Clinical trial data from the STEP program provides precise frequency data: Two mechanisms drive the nausea
Comorbidities: Conditions associated with obesity (diabetes, hypertension, sleep apnea) independently contribute to ED